Belkyra (similar to Kybella) is a fat-dissolving treatment used
to improve the appearance of double chins.
Dr Morunga talks about the process, the ideal candidate, the results and the downtime for Belkyra in this video. Check it out, and get in touch if you have any questions!
BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults.
Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation.
Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury.
BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years.
Allergan New Zealand Limited, Auckland.
Danica Marie Morunga
Editor @ Face Doctors